Frontage Holdings Corporation provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical, biotechnology, and agrochemical companies. Its offerings include medicinal chemistry, pharmacology, ADME screening, DMPK, safety and toxicology, early phase clinical services, bioequivalence, and regulatory support. The company also provides API synthesis, process and formulation development, clinical trial material manufacturing, and laboratory testing such as bioanalysis, biomarkers, genomics, and CMC analytical testing. Founded in 2001 and headquartered in Exton, Pennsylvania, it operates in the United States, Canada, the People's Republic of China, Europe, India, Japan, South Korea, and Australia, and is a subsidiary of Hongkong Tigermed Consulting Co., ltd.